Skip to main content

SSO 2020 Advanced Cancer Therapies Main banner

Tweets by SSO 2020 Advanced Cancer Therapies

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Title

Browse by Title

0 results found.

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

I
Impact of Enhanced Recovery after Surgery Program on Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (PM4)

Favorite

George Salti, MD – Edward-Elmhurst Health ### 915791###Oral Abstract Presenter PM4
Impact of Socioeconomic Status on Outcomes in Colorectal Cancer with Peritoneal Metastases (PM1)

Favorite

Caroline Rieser, MD – University of Pittsburgh Medical Center ### 915790###Oral Abstract Presenter PM1
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent HAI and Systemic Chemotherapy for Colorectal Liver Metastases (HPB2)

Favorite

John M. Creasy, MD – Duke University Medical Center ### 915759###Oral Abstract Presenter HPB2
Inhibition of Neutrophil Extracellular Traps (NETs) with Chloroquine Reduces Peritoneal Metastatic Tumor Burden (AR5)

Favorite

Pavan Rao, MD – Allegheny General Hospital ### 915787###Oral Abstract Presenter AR5
International Comparison of Oncologic Outcomes after Isolated Limb Infusion (ILI) for Advanced Melanoma (M5)

Favorite

Michael J. Carr, MD, MS – Moffitt Cancer Center ### 918093###Oral Abstract Presenter#########
Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center
M5
International Multi-Center Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients (M4)

Favorite

Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital ### 915772###Oral Abstract Presenter#########
Oral Abstract Presenter: Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital
@@@ Michael J. Carr, MD, MS – Moffitt Cancer Center ### 918093###Oral Abstract Presenter#########
Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center
M4
Interventional Radiology (Embolization)

Favorite

Riad Salem, MD – Northwestern University ### 917912###Speaker
Intraperitoneal CMP-001, A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancers (AR6)

Favorite

Carlos HF Chan, MD, PhD – University of Iowa Hospitals and Clinics ### 915756###Oral Abstract Presenter AR6
Invited Lecture: Advances in Neoadjuvant Therapy for Locoregionally Advanced Melanoma: Implications for Clinical Practice and Future Research

Favorite

Ahmad Tarhini, MD, PhD – Moffitt Comprehensive Cancer Center and Research Institute ### 917913###Speaker
Invited Lecture: CAR-T Cell Regional Delivery Approaches

Favorite

Steven Katz, MD – Roger Williams ### 917908###Speaker
Is There Benefit from Hyperthermic Intraperitoneal Chemotherapy in Advanced Gastric Cancer: Early Results from a Phase II Clinical Trial (CT4)

Favorite

James D. McDonald, MD – NIH / Surgical Oncology Program ### 915778###Oral Abstract Presenter CT4
Isolated Limb Perfusion as an Effective Treatment Modality for Locally Advanced Kaposi Sarcoma of the Extremities (M6)

Favorite

Winan van Houdt, MD, PhD – Netherlands Cancer Institute ### 915789###Oral Abstract Presenter M6